Case number 2023-2241
Teva Branded Pharmaceutical Products R&D, Inc. v. Cipla Ltd. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 17, 2025 | 49 | Clerk's closed case letter to Appellant Cipla Ltd. and Appellees Norton (Waterford) Ltd. and Teva Branded Pharmaceutical Products R&D, Inc. Further filings in this closed case will receive no response. Service as of this date by the Clerk of Court. [1097012] [MVH] [Entered: 06/17/2025 02:52 PM] (1) |
| Jun 17, 2025 | 48 | Joint Stipulation of Voluntary Dismissal for Appellant Cipla Ltd. and Appellees Teva Branded Pharmaceutical Products R&D, Inc. and Norton (Waterford) Ltd.. Service: 06/17/2025 by email. [1096953] [23-2241]. No action taken. See Doc. No. [49] [Anil Patel] [Entered: 06/17/2025 12:20 PM] (3) |
| Feb 11, 2025 | 47 | ORDER granting motion to remand [46] filed by Appellees Teva Branded Pharmaceutical Products R&D, Inc., Norton (Waterford) Ltd. and Appellant Cipla Ltd..; issuing mandate. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [1068571] [MVH] [Entered: 02/11/2025 03:45 PM] (2) |
| Feb 5, 2025 | 46 | MOTION of Appellant Cipla Ltd. and Appellees Teva Branded Pharmaceutical Products R&D, Inc. and Norton (Waterford) Ltd. to Remand. Service: 02/05/2025 by email. [1067117] [23-2241] [Anil Patel] [Entered: 02/05/2025 09:43 PM] (12) |
| Feb 3, 2025 | 45 | ORDER filed granting motion to stay appeal [44] filed by Appellees Teva Branded Pharmaceutical Products R&D, Inc., Norton (Waterford) Ltd. and Appellant Cipla Ltd.; Status report due 03/03/2025. Please see the order for full details. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [1066200] [MVH] [Entered: 02/03/2025 03:51 PM] (2) |
| Feb 3, 2025 | 44 | MOTION of Appellant Cipla Ltd. and Appellees Teva Branded Pharmaceutical Products R&D, Inc. and Norton (Waterford) Ltd. to stay appeal. Service: 02/03/2025 by email. [1066061] [23-2241] [Anil Patel] [Entered: 02/03/2025 12:50 PM] (13) |
| Dec 31, 2024 | 43 | Response to notice of oral argument from Appellees Teva Branded Pharmaceutical Products R&D, Inc. and Norton (Waterford) Ltd.. Service: 12/31/2024 by email. [1058008] [23-2241] [Ben Picozzi] [Entered: 12/31/2024 04:57 PM] (1) |
| Dec 31, 2024 | 42 | Response to notice of oral argument from Appellant Cipla Ltd.. Service: 12/31/2024 by email. [1057970] [23-2241] [Anil Patel] [Entered: 12/31/2024 03:30 PM] (1) |
| Dec 17, 2024 | 41 | NOTICE OF ORAL ARGUMENT. Panel: 2502I. Case scheduled February 5, 2025. Response to Notice of Oral Argument due: 12/31/2024. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. Service as of this date by the Clerk of Court. [1055085] [MJL] [Entered: 12/17/2024 05:02 PM] (2) |
| Oct 1, 2024 | 40 | Notice from Appellant Cipla Ltd. regarding conflicts with oral argument. Service: 10/01/2024 by email. [1036322] [23-2241] [Anil Patel] [Entered: 10/01/2024 05:17 PM] (2) |
| Sep 30, 2024 | 39 | Clerk's Note to the File: The court has updated its session calendar for December 2024 through May 2025. Expected arguing counsel should review the revised calendar, available here, to determine whether to file an amended Response to Notice to Advise of Scheduling Conflicts. [1035792] [GWK] [Entered: 09/30/2024 01:59 PM] (0) |
| Apr 10, 2024 | 38 | The following conflict dates submitted by Ben Picozzi for Teva Branded Pharmaceutical Products R&D, Inc. and Norton (Waterford) Ltd. have been accepted by the court: 06/03/2024, 06/04/2024, 06/05/2024, 06/06/2024, 06/07/2024. [996299] [MJL] [Entered: 04/10/2024 08:59 AM] (0) |
| Apr 10, 2024 | 37 | The following conflict dates submitted by Anil Patel for Cipla Ltd. have been accepted by the court: 08/05/2024, 08/06/2024, 08/07/2024, 08/08/2024, 08/09/2024. [996298] [MJL] [Entered: 04/10/2024 08:58 AM] (0) |
| Apr 8, 2024 | 36 | 6 paper copies of Doc. No. [22] received from Appellant Cipla Ltd.. [995886] [VDW] [Entered: 04/09/2024 08:57 AM] (0) |
| Apr 8, 2024 | 35 | Notice from Appellees Teva Branded Pharmaceutical Products R&D, Inc. and Norton (Waterford) Ltd. regarding conflicts with oral argument. Service: 04/08/2024 by email. [995848] [23-2241] [Ben Picozzi] [Entered: 04/08/2024 06:59 PM] (3) |
| Apr 8, 2024 | 34 | Notice from Appellant Cipla Ltd. regarding conflicts with oral argument. Service: 04/08/2024 by email. [995796] [23-2241] [Anil Patel] [Entered: 04/08/2024 03:05 PM] (3) |
| Apr 4, 2024 | 33 | NOTICE OF NON-COMPLIANCE: The paper copies of the reply brief (Doc. No. [32]) provided by Cipla Ltd. are not in compliance with the rules of this court (see attached). Corrected paper copies are due within 5 business days. Service as of this date by the Clerk of Court. [995198] [VDW] [Entered: 04/04/2024 02:20 PM] (2) |
| Apr 4, 2024 | 32 | 6 paper copies of Doc. No. [22], [18] received from Appellant Cipla Ltd.. [995192]. These paper copies are non-compliant. See Doc. No. [33] [VDW] [Entered: 04/04/2024 02:10 PM] (0) |
| Apr 3, 2024 | 31 | 6 paper copies of Doc. No. [27] received from Appellant Cipla Ltd. [995177]--[Edited 04/11/2024 by JCP to update filed date] [IMH] [Entered: 04/04/2024 01:31 PM] (0) |
| Apr 3, 2024 | 30 | 6 paper copies of Doc. No. [19] received from Appellees Norton (Waterford) Ltd. and Teva Branded Pharmaceutical Products R&D, Inc. [995171]--[Edited 04/11/2024 by JCP to update filed date] [IMH] [Entered: 04/04/2024 01:20 PM] (0) |
| Apr 1, 2024 | 29 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [994072] [GWK] [Entered: 04/01/2024 10:35 AM] (1) |
| Apr 1, 2024 | 28 | Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(3)(A). [994070] [GWK] [Entered: 04/01/2024 10:35 AM] (0) |
| Mar 22, 2024 | 27 | MODIFIED ENTRY: APPENDIX FILED by Appellant Cipla Ltd.. Service: 03/22/2024 by email. [992499] --[Edited 04/01/2024 by GWK - compliance review complete] [Anil Patel] [Entered: 03/22/2024 04:18 PM] (768) |
| Mar 19, 2024 | 26 | **TEXT ONLY** ORDER granting motion to extend time to file appendix [25] filed by Appellant Cipla Ltd. The appendix is due 03/26/2024. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [991564] [GWK] [Entered: 03/19/2024 01:42 PM] (0) |
| Mar 15, 2024 | 25 | MOTION of Appellant Cipla Ltd. to extend the time to 03/26/2024 to file the appendix. Service: 03/15/2024 by email. [991115] [23-2241] [Anil Patel] [Entered: 03/15/2024 06:25 PM] (12) |
| Mar 14, 2024 | 24 | Clerk's Note to the File: The time to file the Appellant's Appendix has been extended by 5 days. See [23] and Fed. Cir. R. 26(b)(4). [990753] [GWK] [Entered: 03/14/2024 04:47 PM] (0) |
| Mar 13, 2024 | 23 | Notice from Appellant Cipla Ltd. and Appellees Norton (Waterford) Ltd. and Teva Branded Pharmaceutical Products R&D, Inc. Notice of Additional Time Needed to Resolve Confidentiality Issues Under Fed. Cir. R. 26(b)(4). Service: 03/13/2024 by email. [990534] [23-2241] [Anil Patel] [Entered: 03/13/2024 06:50 PM] (11) |
| Mar 7, 2024 | 22 | MODIFIED ENTRY: REPLY BRIEF FILED by Appellant Cipla Ltd.. Service: 03/07/2024 by email. [989240] --[Edited 03/15/2024 by GWK - compliance review complete] [Anil Patel] [Entered: 03/07/2024 06:00 PM] (36) |
| Feb 27, 2024 | 21 | Notice of Related Case Information for Appellees Teva Branded Pharmaceutical Products R&D, Inc. and Norton (Waterford) Ltd.. Service: 02/27/2024 by email. [987056] [23-2241] [Ben Picozzi] [Entered: 02/27/2024 08:09 PM] (2) |
| Feb 27, 2024 | 20 | Amended Certificate of Interest for Appellees Teva Branded Pharmaceutical Products R&D, Inc. and Norton (Waterford) Ltd.. Service: 02/27/2024 by email. [987055] [23-2241] [Ben Picozzi] [Entered: 02/27/2024 08:08 PM] (3) |
| Feb 15, 2024 | 19 | MODIFIED ENTRY: RESPONSE BRIEF FILED by Appellees Norton (Waterford) Ltd. and Teva Branded Pharmaceutical Products R&D, Inc. Service: 02/15/2024 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [984307] --[Edited 02/26/2024 by GWK - compliance review complete] [Ben Picozzi] [Entered: 02/15/2024 06:22 PM] (95) |
| Nov 20, 2023 | 18 | MODIFIED ENTRY: OPENING BRIEF FILED by Appellant Cipla Ltd. Service: 11/20/2023 by email. [964618] --[Edited 11/28/2023 by ALK - compliance review complete] [Anil Patel] [Entered: 11/20/2023 04:12 PM] (226) |
| Nov 13, 2023 | 17 | ORDER granting motion to extend time to file brief [14] filed by Appellees Teva Branded Pharmaceutical Products R&D, Inc., Norton (Waterford) Ltd. and Appellant Cipla Ltd. The opening brief is due 11/20/2023. The response brief is due 02/15/2024. Service as of this date by the Clerk of Court. [963014] [NL] [Entered: 11/13/2023 03:42 PM] (2) |
| Nov 9, 2023 | 16 | Amended Certificate of Interest for Appellees Teva Branded Pharmaceutical Products R&D, Inc. and Norton (Waterford) Ltd.. Service: 11/09/2023 by email. [962689] [23-2241] [Ben Picozzi] [Entered: 11/09/2023 08:54 PM] (3) |
| Nov 9, 2023 | 15 | Notice of Related Case Information for Appellees Teva Branded Pharmaceutical Products R&D, Inc. and Norton (Waterford) Ltd.. Service: 11/09/2023 by email. [962688] [23-2241] [Ben Picozzi] [Entered: 11/09/2023 08:32 PM] (2) |
| Nov 9, 2023 | 14 | MOTION of Appellant Cipla Ltd. and Appellees Teva Branded Pharmaceutical Products R&D, Inc. and Norton (Waterford) Ltd. to extend the time to file brief. Service: 11/09/2023 by email. [962687] [23-2241] [Anil Patel] [Entered: 11/09/2023 08:26 PM] (19) |
| Nov 9, 2023 | 13 | Notice of Related Case Information for Appellant Cipla Ltd.. Service: 11/09/2023 by email. [962686] [23-2241] [Anil Patel] [Entered: 11/09/2023 08:23 PM] (2) |
| Nov 9, 2023 | 12 | Amended Certificate of Interest for Appellant Cipla Ltd.. Service: 11/09/2023 by email. [962685] [23-2241] [Anil Patel] [Entered: 11/09/2023 08:21 PM] (4) |
| Sep 6, 2023 | 11 | ORDER granting motion to extend time to file brief [10]; The opening brief is due 11/13/2023. The response brief is due 02/01/2024. Service as of this date by the Clerk of Court. [947981] [LMS] [Entered: 09/06/2023 11:25 AM] (2) |
| Aug 28, 2023 | 10 | MOTION of Appellant Cipla Ltd. and Appellees Teva Branded Pharmaceutical Products R&D, Inc. and Norton (Waterford) Ltd. to extend the time to file brief. Service: 08/28/2023 by email. [946231] [23-2241] [Anil Patel] [Entered: 08/28/2023 02:07 PM] (18) |
| Aug 23, 2023 | 9 | Corrected Entry of Appearance for Anil Patel; Peter Giunta; Harold Storey; Adam Berlin as counsel for Appellant Cipla Ltd.. Service: 08/23/2023 by email. [945453] [23-2241] [Anil Patel] [Entered: 08/23/2023 06:45 PM] (2) |
| Aug 21, 2023 | 8 | NOTICE OF NON-COMPLIANCE: The submission of Appellant Cipla Ltd., Entry of Appearance [5], is not in compliance with the rules of this court (see attached). Compliant document due on 08/28/2023. Service as of this date by the Clerk of Court. [944454] [ALK] [Entered: 08/21/2023 10:28 AM] (2) |
| Aug 18, 2023 | 7 | Docketing Statement for the Appellant Cipla Ltd.. Service: 08/18/2023 by email. [944380] [23-2241] [Anil Patel] [Entered: 08/18/2023 06:13 PM] (4) |
| Aug 18, 2023 | 6 | Certificate of Interest for Appellant Cipla Ltd.. Service: 08/18/2023 by email. [944379] [23-2241] [Anil Patel] [Entered: 08/18/2023 06:11 PM] (4) |
| Aug 18, 2023 | 5 | Entry of Appearance for Anil Patel; Peter Giunta; Harold Storey; Adam Berlin as counsel for Appellant Cipla Ltd.. Service: 08/18/2023 by email. [944378] [23-2241] This document is non-compliant. See Doc No. [8]. [Anil Patel] [Entered: 08/18/2023 06:09 PM] (2) |
| Aug 18, 2023 | 4 | Docketing Statement for the Appellees Teva Branded Pharmaceutical Products R&D, Inc. and Norton (Waterford) Ltd.. Service: 08/18/2023 by email. [944361] [23-2241] [David Berl] [Entered: 08/18/2023 04:36 PM] (2) |
| Aug 18, 2023 | 3 | Certificate of Interest for Appellees Teva Branded Pharmaceutical Products R&D, Inc. and Norton (Waterford) Ltd.. Service: 08/18/2023 by email. [944359] [23-2241] [David Berl] [Entered: 08/18/2023 04:35 PM] (3) |
| Aug 18, 2023 | 2 | Entry of Appearance for David I. Berl; Benjamin M. Greenblum; Elise M. Baumgarten; Kathryn S. Kayali; Ben Picozzi; Ricardo Leyva as counsel for Appellees Teva Branded Pharmaceutical Products R&D, Inc. and Norton (Waterford) Ltd.. Service: 08/18/2023 by email. [944358] [23-2241] [David Berl] [Entered: 08/18/2023 04:34 PM] (2) |
| Aug 4, 2023 | 1 | Appeal docketed. Received: 07/28/2023. [940656]Entry of Appearance is due on 08/18/2023. Certificate of Interest is due on 08/18/2023. Docketing Statement is due on 08/18/2023. Appellant's brief is due on 10/03/2023. [ALK] [Entered: 08/04/2023 10:04 AM] (40) |
